Announced Fri, 7 Aug · 18:17 IST
Q1FY27 results: Consolidated revenue up 38%, PAT up 72%
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+14.9%1-day move
₹1249.00
prior close
₹1333.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+5.6+1.8+1.0+1.6+14.9+14.0+15.9+13.9+12.2+11.6————
Up moveDown movePending
AI summary
Entero Healthcare posted Q1FY27 (June 2026) consolidated revenue of Rs 19,405M, up 38% YoY from Rs 14,038M, aided by subsidiaries acquired in FY26. Consolidated PAT rose 72% to Rs 520.51M from Rs 302.32M, with EPS at Rs 8.77 versus Rs 6.39. Standalone revenue grew 5% to Rs 832.66M but standalone PAT fell 50% to Rs 34.57M from Rs 69.57M. Auditor issued an unmodified opinion. Board also reconstituted committees after an independent director's tenure ended.
Likely market impact
Strong consolidated growth, partly from acquisitions; standalone profit dropped 50%, which needs attention.